-
Efficacy and Safety of Radiotherapy Combined with PD-1 Inhibitors and Targeted Therapy for Unresectable Hepatocellular Carcinoma: A Retrospective, Real-World Multicenter Study
10 Feb 2026 22:10 GMT
… kinase inhibitors (lenvatinib, sorafenib, anlotinib and donafenib). … plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma … (IBI305) versus sorafenib in unresectable hepatocellular carcinoma … advanced non-small cell lung cancer. JAMA Oncol. …
-
Enhancing NK Cell Activity in Colorectal Cancer with an Fc-Optimized Antibody Targeting CD276 (B7-H3)
09 Feb 2026 17:48 GMT
… cancer mortality, surpassed by lung cancer.1 The considerable mortality … acute myeloid leukemia and lung cancer,31,34 underscoring its … against non-small cell lung cancer. Front Immunol. 2025; … carcinoma previously treated with sorafenib (KEYNOTE-224): a …
-
Oxygenation: Nanotechnological Strategies for Conquering Tumor Hypoxia in Photodynamic Therapy
09 Feb 2026 17:47 GMT
… in advanced non-small cell lung cancer: a review of the … cancer or non-small-cell lung cancer (consolidative use of radiotherapy … of non-small cell lung cancer in a central… formulation of Tirapazamine and Sorafenib responsive to post-embolization …
-
Anti-Vascular Endothelial Growth Factor Market to Reach US$33.1 Bn by 2032 | Persistence Market Research
05 Feb 2026 15:30 GMT
… , and non-small cell lung cancer.
Driving Factors for Anti- …
Small Molecules
Pazopanib
Sunitinib
Sorafenib
Regorafenib
Cabozantinib
Lenvatinib
Ponatinib
…
Oncology
Non-Small Cell Lung Cancer
Renal Cell Carcinoma
Colorectal Cancer …
-
Bristol Myers Squibb Receives European Commission Approval for Perioperative Regimen of Neoadjuvant Opdivo® (nivolumab) and Chemotherapy Followed by Adjuvant Opdivo for Resectable, High-Risk Non-Small Cell Lung Cancer with PD-L1 Expression ≥1%
16 May 2025 11:14 GMT
… pCR and MPR.
About Lung Cancer
Lung cancer is the leading cause … been previously treated with sorafenib.
OPDIVO® (nivolumab) … metastatic non-small cell lung cancer, in combination with … cell lung cancer; Checkmate 816–neoadjuvant non-small cell lung cancer, …
-
Camrelizumab Combo Doubles 5-Year Survival in Phase 3 Lung Cancer Trial
02 Apr 2025 23:47 GMT
… patients with advanced squamous lung cancer, according to a press … at the 2025 European Lung Cancer Congress (ELCC). The trial … Center consistently shows that lung cancer has the highest incidence … 15.2 months with sorafenib. Median progression-free survival …
-
Bristol Myers Squibb Receives Positive CHMP Opinion for Perioperative Regimen of Neoadjuvant Opdivo® (nivolumab) and Chemotherapy Followed by Surgery and Adjuvant Opdivo for Resectable Non-Small Cell Lung Cancer in Patients with Tumor Cell PD-L1...
28 Mar 2025 13:11 GMT
… of four tumor types: lung cancer, bladder cancer, esophageal … pathologic response.
About Lung Cancer
Lung cancer is the leading cause … been previously treated with sorafenib. This indication is … lung cancer; Checkmate 816–neoadjuvant non-small cell lung cancer, …
-
Bristol Myers Squibb Announces Opdivo® Plus Chemotherapy as the First and Only Neoadjuvant-Only Immuno-Oncology Therapy to Demonstrate Statistically Significant and Clinically Meaningful Overall Survival in Resectable Non-Small Cell Lung Cancer
19 Feb 2025 12:09 GMT
… positive) non-small cell lung cancer (NSCLC).
OPDIVO® (nivolumab … been previously treated with sorafenib. This indication is … metastatic non-small cell lung cancer, in combination with … cell lung cancer; Checkmate 816–neoadjuvant non-small cell lung cancer, …
-
Plant-Derived Exosome-Like Nanoparticles: Mechanisms of Cross-Kingdom Regulation and Perspectives as Natural Drug Carriers for Disease Treatment
02 Feb 2026 13:58 GMT
… human non-small cell lung cancer cells by inducing cell … cytotoxicity in renal and lung cancers, promoting S-phase arrest … facilitated oral delivery of sorafenib and improved hepatic targeting … STAT3 pathway inhibition in A549 lung cancer cells. Mol Med Rep. …
-
A Comprehensive Review of Advances in Molecular Mechanisms and Targeted Therapies for the Specific Type of Cystic Lung Cancer
11 Feb 2025 15:06 GMT
… is the most neuroendocrine lung tumor, and it also … Lung cancers associated with cystic airspaces: CT features and pathologic correlation. Lung Cancer … Raez LE. Efficacy of sorafenib, a multi-tyrosine kinase … -L1 expression in rare lung tumors. Pathol Oncol Res. …
About
© 1995-2026